Copyright Reports & Markets. All rights reserved.

Global Cardiac Drug Balloon Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cardiac Drug Balloon Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Cardiac Glycosides
    • 1.3.3 Non-glycosides
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cardiac Drug Balloon Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Cardiac Catheterization Laboratory
  • 1.5 Global Cardiac Drug Balloon Market Size & Forecast
    • 1.5.1 Global Cardiac Drug Balloon Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Cardiac Drug Balloon Sales Quantity (2020-2031)
    • 1.5.3 Global Cardiac Drug Balloon Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Boston Scientifc
    • 2.1.1 Boston Scientifc Details
    • 2.1.2 Boston Scientifc Major Business
    • 2.1.3 Boston Scientifc Cardiac Drug Balloon Product and Services
    • 2.1.4 Boston Scientifc Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Boston Scientifc Recent Developments/Updates
  • 2.2 Medtronic
    • 2.2.1 Medtronic Details
    • 2.2.2 Medtronic Major Business
    • 2.2.3 Medtronic Cardiac Drug Balloon Product and Services
    • 2.2.4 Medtronic Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Medtronic Recent Developments/Updates
  • 2.3 AR BALTIC
    • 2.3.1 AR BALTIC Details
    • 2.3.2 AR BALTIC Major Business
    • 2.3.3 AR BALTIC Cardiac Drug Balloon Product and Services
    • 2.3.4 AR BALTIC Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 AR BALTIC Recent Developments/Updates
  • 2.4 BD
    • 2.4.1 BD Details
    • 2.4.2 BD Major Business
    • 2.4.3 BD Cardiac Drug Balloon Product and Services
    • 2.4.4 BD Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 BD Recent Developments/Updates
  • 2.5 B. Braun Melsungen
    • 2.5.1 B. Braun Melsungen Details
    • 2.5.2 B. Braun Melsungen Major Business
    • 2.5.3 B. Braun Melsungen Cardiac Drug Balloon Product and Services
    • 2.5.4 B. Braun Melsungen Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 B. Braun Melsungen Recent Developments/Updates
  • 2.6 Koninklijke Philips
    • 2.6.1 Koninklijke Philips Details
    • 2.6.2 Koninklijke Philips Major Business
    • 2.6.3 Koninklijke Philips Cardiac Drug Balloon Product and Services
    • 2.6.4 Koninklijke Philips Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Koninklijke Philips Recent Developments/Updates
  • 2.7 Boston Scientific
    • 2.7.1 Boston Scientific Details
    • 2.7.2 Boston Scientific Major Business
    • 2.7.3 Boston Scientific Cardiac Drug Balloon Product and Services
    • 2.7.4 Boston Scientific Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Boston Scientific Recent Developments/Updates
  • 2.8 Opto Circuits
    • 2.8.1 Opto Circuits Details
    • 2.8.2 Opto Circuits Major Business
    • 2.8.3 Opto Circuits Cardiac Drug Balloon Product and Services
    • 2.8.4 Opto Circuits Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Opto Circuits Recent Developments/Updates
  • 2.9 AR Baltic Medical
    • 2.9.1 AR Baltic Medical Details
    • 2.9.2 AR Baltic Medical Major Business
    • 2.9.3 AR Baltic Medical Cardiac Drug Balloon Product and Services
    • 2.9.4 AR Baltic Medical Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 AR Baltic Medical Recent Developments/Updates
  • 2.10 Acrostak
    • 2.10.1 Acrostak Details
    • 2.10.2 Acrostak Major Business
    • 2.10.3 Acrostak Cardiac Drug Balloon Product and Services
    • 2.10.4 Acrostak Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Acrostak Recent Developments/Updates
  • 2.11 Grandpharma (China) Co., Ltd.
    • 2.11.1 Grandpharma (China) Co., Ltd. Details
    • 2.11.2 Grandpharma (China) Co., Ltd. Major Business
    • 2.11.3 Grandpharma (China) Co., Ltd. Cardiac Drug Balloon Product and Services
    • 2.11.4 Grandpharma (China) Co., Ltd. Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Grandpharma (China) Co., Ltd. Recent Developments/Updates
  • 2.12 Yinyi(liaoning)Biotech CO.,LTD.
    • 2.12.1 Yinyi(liaoning)Biotech CO.,LTD. Details
    • 2.12.2 Yinyi(liaoning)Biotech CO.,LTD. Major Business
    • 2.12.3 Yinyi(liaoning)Biotech CO.,LTD. Cardiac Drug Balloon Product and Services
    • 2.12.4 Yinyi(liaoning)Biotech CO.,LTD. Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Yinyi(liaoning)Biotech CO.,LTD. Recent Developments/Updates
  • 2.13 Acotec Scientific Holdings Limited
    • 2.13.1 Acotec Scientific Holdings Limited Details
    • 2.13.2 Acotec Scientific Holdings Limited Major Business
    • 2.13.3 Acotec Scientific Holdings Limited Cardiac Drug Balloon Product and Services
    • 2.13.4 Acotec Scientific Holdings Limited Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Acotec Scientific Holdings Limited Recent Developments/Updates
  • 2.14 Lutonix
    • 2.14.1 Lutonix Details
    • 2.14.2 Lutonix Major Business
    • 2.14.3 Lutonix Cardiac Drug Balloon Product and Services
    • 2.14.4 Lutonix Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Lutonix Recent Developments/Updates
  • 2.15 Medrad
    • 2.15.1 Medrad Details
    • 2.15.2 Medrad Major Business
    • 2.15.3 Medrad Cardiac Drug Balloon Product and Services
    • 2.15.4 Medrad Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Medrad Recent Developments/Updates
  • 2.16 Biotronik
    • 2.16.1 Biotronik Details
    • 2.16.2 Biotronik Major Business
    • 2.16.3 Biotronik Cardiac Drug Balloon Product and Services
    • 2.16.4 Biotronik Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Biotronik Recent Developments/Updates
  • 2.17 Eurocor GmbH
    • 2.17.1 Eurocor GmbH Details
    • 2.17.2 Eurocor GmbH Major Business
    • 2.17.3 Eurocor GmbH Cardiac Drug Balloon Product and Services
    • 2.17.4 Eurocor GmbH Cardiac Drug Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Eurocor GmbH Recent Developments/Updates

3 Competitive Environment: Cardiac Drug Balloon by Manufacturer

  • 3.1 Global Cardiac Drug Balloon Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Cardiac Drug Balloon Revenue by Manufacturer (2020-2025)
  • 3.3 Global Cardiac Drug Balloon Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Cardiac Drug Balloon by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Cardiac Drug Balloon Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Cardiac Drug Balloon Manufacturer Market Share in 2024
  • 3.5 Cardiac Drug Balloon Market: Overall Company Footprint Analysis
    • 3.5.1 Cardiac Drug Balloon Market: Region Footprint
    • 3.5.2 Cardiac Drug Balloon Market: Company Product Type Footprint
    • 3.5.3 Cardiac Drug Balloon Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cardiac Drug Balloon Market Size by Region
    • 4.1.1 Global Cardiac Drug Balloon Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Cardiac Drug Balloon Consumption Value by Region (2020-2031)
    • 4.1.3 Global Cardiac Drug Balloon Average Price by Region (2020-2031)
  • 4.2 North America Cardiac Drug Balloon Consumption Value (2020-2031)
  • 4.3 Europe Cardiac Drug Balloon Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Cardiac Drug Balloon Consumption Value (2020-2031)
  • 4.5 South America Cardiac Drug Balloon Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Cardiac Drug Balloon Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Cardiac Drug Balloon Sales Quantity by Type (2020-2031)
  • 5.2 Global Cardiac Drug Balloon Consumption Value by Type (2020-2031)
  • 5.3 Global Cardiac Drug Balloon Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Cardiac Drug Balloon Sales Quantity by Application (2020-2031)
  • 6.2 Global Cardiac Drug Balloon Consumption Value by Application (2020-2031)
  • 6.3 Global Cardiac Drug Balloon Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Cardiac Drug Balloon Sales Quantity by Type (2020-2031)
  • 7.2 North America Cardiac Drug Balloon Sales Quantity by Application (2020-2031)
  • 7.3 North America Cardiac Drug Balloon Market Size by Country
    • 7.3.1 North America Cardiac Drug Balloon Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Cardiac Drug Balloon Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Cardiac Drug Balloon Sales Quantity by Type (2020-2031)
  • 8.2 Europe Cardiac Drug Balloon Sales Quantity by Application (2020-2031)
  • 8.3 Europe Cardiac Drug Balloon Market Size by Country
    • 8.3.1 Europe Cardiac Drug Balloon Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Cardiac Drug Balloon Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cardiac Drug Balloon Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Cardiac Drug Balloon Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Cardiac Drug Balloon Market Size by Region
    • 9.3.1 Asia-Pacific Cardiac Drug Balloon Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Cardiac Drug Balloon Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Cardiac Drug Balloon Sales Quantity by Type (2020-2031)
  • 10.2 South America Cardiac Drug Balloon Sales Quantity by Application (2020-2031)
  • 10.3 South America Cardiac Drug Balloon Market Size by Country
    • 10.3.1 South America Cardiac Drug Balloon Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Cardiac Drug Balloon Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cardiac Drug Balloon Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Cardiac Drug Balloon Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Cardiac Drug Balloon Market Size by Country
    • 11.3.1 Middle East & Africa Cardiac Drug Balloon Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Cardiac Drug Balloon Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Cardiac Drug Balloon Market Drivers
  • 12.2 Cardiac Drug Balloon Market Restraints
  • 12.3 Cardiac Drug Balloon Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cardiac Drug Balloon and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cardiac Drug Balloon
  • 13.3 Cardiac Drug Balloon Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cardiac Drug Balloon Typical Distributors
  • 14.3 Cardiac Drug Balloon Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cardiac Drug Balloon market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Cardiac Drug Balloon market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cardiac Drug Balloon market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Cardiac Drug Balloon market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Cardiac Drug Balloon market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Cardiac Drug Balloon market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cardiac Drug Balloon
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cardiac Drug Balloon market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientifc, Medtronic, AR BALTIC, BD, B. Braun Melsungen, Koninklijke Philips, Boston Scientific, Opto Circuits, AR Baltic Medical, Acrostak, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cardiac Drug Balloon market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Cardiac Glycosides
    Non-glycosides
    Market segment by Application
    Hospital
    Cardiac Catheterization Laboratory
    Major players covered
    Boston Scientifc
    Medtronic
    AR BALTIC
    BD
    B. Braun Melsungen
    Koninklijke Philips
    Boston Scientific
    Opto Circuits
    AR Baltic Medical
    Acrostak
    Grandpharma (China) Co., Ltd.
    Yinyi(liaoning)Biotech CO.,LTD.
    Acotec Scientific Holdings Limited
    Lutonix
    Medrad
    Biotronik
    Eurocor GmbH
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cardiac Drug Balloon product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cardiac Drug Balloon, with price, sales quantity, revenue, and global market share of Cardiac Drug Balloon from 2020 to 2025.
    Chapter 3, the Cardiac Drug Balloon competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cardiac Drug Balloon breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cardiac Drug Balloon market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiac Drug Balloon.
    Chapter 14 and 15, to describe Cardiac Drug Balloon sales channel, distributors, customers, research findings and conclusion.

    Buy now